As of March 31, 2026, Avalon GloboCare Corp. carries a market capitalization of 88.43M, placing it among publicly traded companies globally. Its enterprise value stands at 115.89M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 88.43M |
| Enterprise Value | 115.89M |
As of March 31, 2026, Avalon GloboCare Corp. has 8.32M shares outstanding.
| Shares Outstanding | 8.32M |
These figures are as of March 31, 2026. The price-to-sales ratio is -152.24, and the price-to-book ratio stands at -5.86.
| PS Ratio | -152.24 |
| PB Ratio | -5.86 |
| P/TBV Ratio | -3.00 |
| P/FCF Ratio | -8.65 |
| P/OCF Ratio | -8.65 |
As of March 31, 2026, Avalon GloboCare Corp. maintains a current ratio of 0.38, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.10, indicating elevated leverage, while an interest coverage ratio of -6.67 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.38 |
| Quick Ratio | 0.28 |
| Debt / Equity | 12.10 |
| Debt / EBITDA | -0.18 |
| Interest Coverage | -6.67 |
These figures cover the twelve months ended March 31, 2026. Return on assets (ROA) is negative at -150.87, reflecting losses generated across the asset base. The company generates approximately -99,942.86 in revenue per employee across its workforce of 3.50, a quick read on workforce productivity versus industry peers.
| Return on Assets (ROA) | -150.87 |
| Revenue Per Employee | -99,942.86 |
| Employee Count | 3.50 |
As of the close on July 21, 2026, Avalon GloboCare Corp.'s stock has declined approximately 87.84% over the past 52 weeks. The 50-day moving average sits at 0.33, while the 200-day moving average is 0.95.
| 52-Week Price Change | -87.84% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.95 |
Over the twelve months ended March 31, 2026, Avalon GloboCare Corp. generated -349,800.00 in revenue and converted that into -20.26M in net income, yielding earnings per share of -3.87. EBITDA reached -7.79M, while operating income came in at -8.51M.
| Revenue | -349,800.00 |
| Operating Income | -8.51M |
| Pretax Income | -19.41M |
| Net Income | -20.26M |
| EBITDA | -7.79M |
| EBIT | -8.51M |
| Earnings Per Share (EPS) | -3.87 |
As of March 31, 2026, Avalon GloboCare Corp. holds 775,995.00 in cash and equivalents against 1.42M in total debt, resulting in a net debt position of 481,832.00. Total book value stands at -15.10M, with working capital of -2.77M providing operational flexibility.
| Cash & Cash Equivalents | 775,995.00 |
| Total Debt | 1.42M |
| Net Debt | 481,832.00 |
| Equity (Book Value) | -15.10M |
| Book Value Per Share | -1.81 |
| Working Capital | -2.77M |
Avalon GloboCare Corp. produced -6.16M in operating cash flow over the twelve months ended March 31, 2026.
| Operating Cash Flow | -6.16M |
| Free Cash Flow | -6.16M |
| FCF Per Share | -1.23 |
These figures cover the twelve months ended March 31, 2026. The operating margin of 2,431.59 and net profit margin of 5,791.47 provide insight into operational efficiency.
| Operating Margin | 2,431.59 |
| Pretax Margin | 5,549.87 |
| Profit Margin | 5,791.47 |
| EBITDA Margin | 2,225.97 |
These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -11.56: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -5.22, meaning Avalon GloboCare Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -5.22 |
| FCF Yield | -11.56 |
Avalon GloboCare Corp.'s most recent stock split took place on October 28, 2024 with a 15:1 split ratio.
| Last Split Date | 10/28/2024 |
| Split Ratio | 15:1 |
As of March 31, 2026, Avalon GloboCare Corp. has an Altman Z-Score of -90.41, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -90.41 |